SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
Date of Report (Date of earliest event reported) May 6, 2003
| |
| EPOCH BIOSCIENCES, INC. |
|
| (Exact name of Registrant as specified in charter) |
| | | | | |
| Delaware | | 0-22170 | | 91-1311592 |
| |
| |
|
(State or other jurisdiction
of incorporation) | | (Commission
File Number) | | (I.R.S. Employer
Identification No.) |
| | | |
| 21720 23rd Drive S.E., Suite 150, Bothell, Washington | | 98021 |
| |
|
| (Address of principal executive offices) | | (Zip Code) |
Registrant’s telephone number, including area code (425) 482-5555
| |
| |
|
| (Former name or former address, if changed, since last report.) |
Page 1 of 5 Pages
Exhibit Index is on Page 4
TABLE OF CONTENTS
Item 7. Exhibits
| | | |
| Exhibit | | |
| Number | | |
| | |
| 99.1 | | Press Release dated May 6, 2003 |
Item 9. –Regulation FD Disclosure
On May 6, 2003, Epoch Biosciences, Inc. issued a press release to report its financial results for the quarter ended March 31, 2003. The press release is attached hereto as Exhibit 99.1 and is incorporated herein by reference.
All of the foregoing information is being furnished under Item 12 – Results of Operations and Financial Condition. It is being furnished under Item 9 of this Form 8-K in accordance with interim guidance issued by the SEC in Release No. 33-8216. Such information, including the Exhibits attached hereto, shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933.
2
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this Report to be signed on its behalf by the undersigned thereunto duly authorized.
| | | | | |
| | | EPOCH BIOSCIENCES, INC. |
| | | | | |
| Date: May 6, 2003 | | By: | | /s/ Bert W. Hogue |
| | | | |
|
| | | | | Bert W. Hogue
Vice President and
Chief Financial Officer |
3
EXHIBIT INDEX
The following exhibits are attached hereto and incorporated herein by reference:
| | | | | | | |
| Exhibit | | | | Sequentially |
| Number | | | | Numbered Page |
| | | |
|
| 99.1 | | Press Release dated May 6, 2003 | | | - | |
4
